Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic.

Chanchai, Rattanachai; Kanjanavanit, Rungsrit; Leemasawat, Krit; Amarittakomol, Anong; Topaiboon, Paleerat; Phrommintikul, Arintaya

Chanchai, Rattanachai; Kanjanavanit, Rungsrit; Leemasawat, Krit; Amarittakomol, Anong; Topaiboon, Paleerat; Phrommintikul, Arintaya.

Afiliación

Chanchai R; Northern Cardiac Center, Faculty of Medicine, Chiang Mai UniversityChiang MaiThailand.
Kanjanavanit R; Northern Cardiac Center, Faculty of Medicine, Chiang Mai UniversityChiang MaiThailand.
Leemasawat K; Department of Internal Medicine, Faculty of Medicine, Chiang Mai UniversityChiang MaiThailand.
Amarittakomol A; Northern Cardiac Center, Faculty of Medicine, Chiang Mai UniversityChiang MaiThailand.
Topaiboon P; Northern Cardiac Center, Faculty of Medicine, Chiang Mai UniversityChiang MaiThailand.
Phrommintikul A; Northern Cardiac Center, Faculty of Medicine, Chiang Mai UniversityChiang MaiThailand.

J Drug Assess ; 7(1): 8-13, 2018.

Article en En | MEDLINE | ID: mdl-29379674

Palabras clave

Beta-blocker; brand drug; generic drug; heart failure; tolerability

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Drug Assess Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google